BACKGROUND: After decades of obscurity, Zika virus (ZIKV) has spread through the Americas since 2015 accompanied by congenital microcephaly and Guillain-Barré syndrome. Although these epidemics presumably involve transmission by Aedes aegypti, no direct evidence of vector involvement has been reported, prompting speculation that other mosquitoes such as Culex quinquefasciatus could be involved. METHODS: We detected an outbreak of ZIKV infection in southern Mexico in late 2015. Sera from suspected ZIKV-infected patients were analyzed for viral RNA and antibodies. Mosquitoes were collected in and around patient homes and tested for ZIKV. RESULTS: Of 119 suspected ZIKV-infected patients, 25 (21%) were confirmed by RT-PCR of serum collected 1-8 days after the onset of signs and symptoms including rash, arthralgia, headache, pruritus, myalgia, and fever. Of 796 mosquitoes collected, A. aegypti yielded ZIKV detection by RT-PCR in 15 of 55 pools (27.3%). No ZIKV was detected in C. quinquefasciatus ZIKV sequences derived from sera and mosquitoes showed a monophyletic relationship suggestive of a point source introduction from Guatemala. CONCLUSIONS: These results demonstrate the continued, rapid northward progression of ZIKV into North America with typically mild disease manifestations, and implicate A. aegypti for the first time as a principal vector in North America.
BACKGROUND: After decades of obscurity, Zika virus (ZIKV) has spread through the Americas since 2015 accompanied by congenital microcephaly and Guillain-Barré syndrome. Although these epidemics presumably involve transmission by Aedes aegypti, no direct evidence of vector involvement has been reported, prompting speculation that other mosquitoes such as Culex quinquefasciatus could be involved. METHODS: We detected an outbreak of ZIKV infection in southern Mexico in late 2015. Sera from suspected ZIKV-infectedpatients were analyzed for viral RNA and antibodies. Mosquitoes were collected in and around patient homes and tested for ZIKV. RESULTS: Of 119 suspected ZIKV-infectedpatients, 25 (21%) were confirmed by RT-PCR of serum collected 1-8 days after the onset of signs and symptoms including rash, arthralgia, headache, pruritus, myalgia, and fever. Of 796 mosquitoes collected, A. aegypti yielded ZIKV detection by RT-PCR in 15 of 55 pools (27.3%). No ZIKV was detected in C. quinquefasciatusZIKV sequences derived from sera and mosquitoes showed a monophyletic relationship suggestive of a point source introduction from Guatemala. CONCLUSIONS: These results demonstrate the continued, rapid northward progression of ZIKV into North America with typically mild disease manifestations, and implicate A. aegypti for the first time as a principal vector in North America.
Authors: Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines Journal: N Engl J Med Date: 2016-03-04 Impact factor: 91.245
Authors: Esteban E Díaz-González; Tiffany F Kautz; Alicia Dorantes-Delgado; Iliana R Malo-García; Maricela Laguna-Aguilar; Rose M Langsjoen; Rubing Chen; Dawn I Auguste; Rosa M Sánchez-Casas; Rogelio Danis-Lozano; Scott C Weaver; Ildefonso Fernández-Salas Journal: Am J Trop Med Hyg Date: 2015-09-28 Impact factor: 2.345
Authors: E Oehler; L Watrin; P Larre; I Leparc-Goffart; S Lastere; F Valour; L Baudouin; Hp Mallet; D Musso; F Ghawche Journal: Euro Surveill Date: 2014-03-06
Authors: Lynn J Miller; Farooq Nasar; Christopher W Schellhase; Sarah L Norris; Adrienne E Kimmel; Stephanie M Valdez; Suzanne E Wollen-Roberts; Joshua D Shamblin; Thomas R Sprague; Luis A Lugo-Roman; Richard G Jarman; In-Kyu Yoon; Maria T Alera; Sina Bavari; M Louise M Pitt; Andrew D Haddow Journal: Am J Trop Med Hyg Date: 2018-02-01 Impact factor: 2.345
Authors: John A Vanchiere; Julio C Ruiz; Alan G Brady; Thomas J Kuehl; Lawrence E Williams; Wallace B Baze; Gregory K Wilkerson; Pramod N Nehete; Gloria B McClure; Donna L Rogers; Shannan L Rossi; Sasha R Azar; Christopher M Roundy; Scott C Weaver; Nikos Vasilakis; Joe H Simmons; Christian R Abee Journal: Am J Trop Med Hyg Date: 2018-01-01 Impact factor: 2.345
Authors: Tereza Magalhaes; Brian D Foy; Ernesto T A Marques; Gregory D Ebel; James Weger-Lucarelli Journal: Virus Res Date: 2017-07-11 Impact factor: 3.303
Authors: Gilberto E Felix; Roberto Barrera; Jesus Vazquez; Kyle R Ryff; Jorge L Munoz-Jordan; Katia Y Matias; Ryan R Hemme Journal: J Am Mosq Control Assoc Date: 2018-09 Impact factor: 0.917
Authors: Sasha R Azar; Christopher M Roundy; Shannan L Rossi; Jing H Huang; Grace Leal; Ruimei Yun; Ildefonso Fernandez-Salas; Christopher J Vitek; Igor A D Paploski; Pamela M Stark; Jeremy Vela; Mustapha Debboun; Martin Reyna; Uriel Kitron; Guilherme S Ribeiro; Kathryn A Hanley; Nikos Vasilakis; Scott C Weaver Journal: Am J Trop Med Hyg Date: 2017-08 Impact factor: 2.345
Authors: Forrest T Goodfellow; Blanka Tesla; Gregory Simchick; Qun Zhao; Thomas Hodge; Melinda A Brindley; Steven L Stice Journal: Stem Cells Dev Date: 2016-10-17 Impact factor: 3.272